Fennec Pharmaceuticals Inc
F:RV41
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fennec Pharmaceuticals Inc
F:RV41
|
US |
|
E
|
EchoStar Corp
F:E20
|
US |
|
B
|
Bank of Nova Scotia
F:BKN
|
CA |
|
C
|
CRH PLC
F:CRG
|
IE |
|
G
|
Genuine Parts Co
DUS:GPT
|
US |
|
Banco de Sabadell SA
F:BDSB
|
ES |
|
S
|
System1 Group PLC
XBER:BBA
|
UK |
|
Life Healthcare Group Holdings Ltd
OTC:LTGHF
|
ZA |
|
T
|
Teva Pharmaceutical Industries Ltd
SWB:TEV
|
IL |
|
C
|
Coherus BioSciences Inc
F:8C5
|
US |
|
M
|
Moshi Moshi Retail Corporation PCL
SET:MOSHI
|
TH |
|
C
|
Cintas Corp
XBER:CIT
|
US |
|
Fomento de Construcciones y Contratas SA
F:FCC
|
ES |
|
A
|
AK Alrosa PAO
MOEX:ALRS
|
RU |
|
D
|
Deutsche Boerse AG
XBER:DB1
|
DE |
|
U
|
United Rentals Inc
XBER:UR3
|
US |
|
Imperial Oil Ltd
TSX:IMO
|
CA |
Wall St Price Targets
RV41 Price Targets Summary
Fennec Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RV41 is 13.51 EUR with a low forecast of 11.17 EUR and a high forecast of 16.08 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV41's stock price target?
Price Target
13.51
EUR
According to Wall Street analysts, the average 1-year price target for RV41 is 13.51 EUR with a low forecast of 11.17 EUR and a high forecast of 16.08 EUR.
What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
48%
The compound annual growth rate for Revenue over the next 3 years is 48%.
What is the Gross Profit forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
46%
The compound annual growth rate for Gross Profit over the next 3 years is 46%.
